The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
https://www.frontiersin.org/articles/10.3389/fpubh.2020.00185/full
Paul Harrison - hyper in chief ?
Why no progress ??
Capital raised 14th March specifically for the construction of the transmission line and Tenders awarded 16th April.
Nothing has been started - why ?
FT showing 6.5m volume - here only 1,3m shares.
A very big buyer in the background. Bid? coming?
Someone knows something.
Agree notmski1 - read the report.
It is well researched and everything rings true. Valuation absurd.
GameStop has fallen back leaving a lot of losers.
This share is a pure punt but you’ll get better odds at Cheltenham.
No mention of the graphite project where news was expected in Q4 last year.
Were Willetts and Paul Harrison ramping something purely to get the capital raise in the summer away. Harrison had form with Strategic Minerals.
https://www.talgagroup.com/irm/PDF/5cd02e9a-1c1c-492a-8e2c-fab8040a3ea9/WebinarPresentation
Let’s just hope another country like the USA take our treatment seriously. Boris & his mates seem to have little interest in therapeutics - its vaccines vaccines vaccines and nothing else. If it passes phase3 trials in the USA, production is in the US, then Boris & co can whistle in the wind for supplies in the UK. As I’m in the high risk category aged over 65 and believe in this treatment I will pay for it through MAP if I need it but no doubt UK bureaucracy will make it difficult to obtain.
As a high risk person who receives letters and emails from the NHS can I buy this treatment if I catch the virus ?
Or do I have to play Russian roulette ? Risk of getting an unloaded nebuliser!
Surely this has been proved over the last 10 years its safe and for the NHS to buy they need proof it works. Ok accepted.
But why oh why can we not have access to it if we catch the virus if we so wish ?
Why agree an offer so far below the NAV.
The declared NAV must be accounting mumbo jumbo with the real realisable NAV nearer this offer value adjusted for time value.
Yes - Nymox Pharmaceutical.(NYMX:NAQ).
They have spent about the sametime as Synairgen developing a non-invasive treatment for enlarged prostates which affect most men after a certain age. They are about to file for FDA approval after completing Phase 3 tests.
The SP has come off from a high in late June due to Covid delays in filing but expect to now file in the very near future.
On filing SP is expected to more than double. Same sort of exit valuations talked about as Synairgen.
But what about the people at risk who haven’t got access if they unfortunately catch the virus. Are they going to die so our politicians don’t lose face.
It just appears politicians keep banging on and splurging our taxes on them V2 rocket of vaccines rather than putting real help behind the SNG trials.